Novartis Ag (NVS) Restructuring Costs (2009 - 2013)

Novartis Ag has disclosed Restructuring Costs across 5 years of filings, most recently posting -$65.0 million for Q4 2013.

• In Q4 2013, Restructuring Costs fell 91.18% year-over-year to -$65.0 million; the TTM figure through Dec 2013 stood at -$449.0 million (down 5.9% YoY), while the FY2010 annual figure was -$158.0 million, down 295.0% from the prior year.
• Restructuring Costs came in at -$65.0 million for Q4 2013 at Novartis Ag, down from -$34.0 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of -$34.0 million in Q4 2012 to a low of -$192.0 million in Q4 2011.
• Average Restructuring Costs over 5 years is -$97.8 million, with a median of -$65.0 million recorded in 2013.
• Year-over-year, Restructuring Costs tumbled 295.0% in 2010 and surged 82.29% in 2012.
• Over 5 years, Restructuring Costs stood at -$40.0 million in 2009, then plunged by 295.0% to -$158.0 million in 2010, then retreated by 21.52% to -$192.0 million in 2011, then surged by 82.29% to -$34.0 million in 2012, then tumbled by 91.18% to -$65.0 million in 2013.
• Per Business Quant data, the three most recent Restructuring Costs figures were -$65.0 million in Q4 2013, -$34.0 million in Q4 2012, and -$192.0 million in Q4 2011.